Altre lingue TrivarX Limited

Azioni

TRI

AU0000300196

Prezzo di chiusura Australian S.E. Altri mercati azionari 00:00:00 06/05/2024			Variaz. 5gg	Var. 1 gen.
0,035 ^AUD	+9,38%		+34,62%	+16,67%

02/05	TrivarX riceve impegni fermi per un'emissione di azioni da 2,5 milioni di dollari australiani; le azioni salgono del 27%.	MT
28/02	TrivarX Limited riporta i risultati degli utili per il semestre terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

TrivarX Receives Firm Commitments for AU$2.5 Million Share Issuance; Shares Jump 27%	02/05
TrivarX Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28/02
TrivarX Signs Collaboration with Northern Michigan University on Sleep Research	09/02
TrivarX Secures R&D Tax Rebate for Fiscal Year 2023; Shares Fall 4%	08/02
Over Half of Patients On Track for Completion in TrivarX's SAMDE Study	07/02
TrivarX Undertaking 1-for-20 Securities Consolidation	18/10/23
Medibio Limited has Changed its Name to TrivarX Limited	06/10/23
Medibio Limited Announces Dr. Thomas Young Will Transition from His Role as Part-Time Chief Executive Officer to Non-Executive Director	06/10/23
Medibio Limited Announces Dr. Thomas Young Will Transition from His Role as Part-Time Chief Executive Officer to Non-Executive Director	06/10/23
Medibio Begins Phase Two Trial for Sleep Algorithm	04/09/23
TrivarX Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23
Medibio Completes Phase One Depressive Episode Sleep Trial	24/07/23
US FDA Denies Breakthrough Device Designation for Medibio’s Depression Diagnostic Device	21/07/23
Medibio Completes Shares Purchase Plan	29/05/23
Medibio Adds Executive Director Role to CEO, Changes Principal Pace of Business	12/04/23
Medibio Limited Announces Board & Management Changes	12/04/23
Medibio Limited Announces Change of Registered Office and Principal Place of Business	12/04/23
Medibio Limited Announces Resignation of Matt Mesnik as Non-Executive Director	16/03/23
Medibio Limited Lodges Breakthrough Device Designation with FDA	26/02/23
TrivarX Limited Reports Earnings Results for the Half Year Ended December 31, 2022	24/02/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue TrivarX Limited

Azioni

TRI

AU0000300196

Altre lingue

Filtri